STRATA CRITICAL MEDICAL, INC. Cost of Revenue
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Cost of Revenue of $57.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. cost of revenue for the quarter ending 2026-06-30 was $57.29M, a 58.70% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for the quarter ending 2026-03-31 was $53.27M, a 84.35% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for the quarter ending 2025-12-31 was $55.12M, a 75.68% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for the quarter ending 2025-09-30 was $37.68M, a 31.97% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for fiscal 2025 was $156.01M, a 33.09% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for fiscal 2024 was $117.23M, a 35.96% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for fiscal 2023 was $183.06M, a 47.81% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. cost of revenue for fiscal 2022 was $123.84M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $57.29M 10-Q · filed 2026-08-04 | $110.56M 10-Q · filed 2026-08-04 | $165.68M derived: sum of 3 quarters · filed 2026-08-04 | $203.36M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $53.27M 10-Q · filed 2026-05-06 | $108.38M derived: sum of 2 quarters · filed 2026-05-06 | $146.07M derived: sum of 3 quarters · filed 2026-05-06 | $182.17M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $55.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $92.80M derived: sum of 2 quarters · filed 2026-03-03 | $128.90M derived: sum of 3 quarters · filed 2026-08-04 | $156.01M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $37.68M 10-Q · filed 2025-11-10 | $73.78M derived: sum of 2 quarters · filed 2026-08-04 | $100.90M 10-Q · filed 2025-11-10 | $134.05M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $36.10M 10-Q · filed 2026-08-04 | $53.06M 10-Q · filed 2025-08-05 | $65.00M 10-Q · filed 2026-08-04 | $95.39M 10-Q · filed 2025-08-05 | $96.37M derived: sum of 3 quarters · filed 2026-08-04 | $124.92M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $28.89M 10-Q · filed 2026-05-06 | $42.33M 10-Q · filed 2025-05-12 | $60.27M derived: sum of 2 quarters · filed 2026-05-06 | $88.82M derived: sum of 3 quarters · filed 2026-05-06 | $140.41M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $31.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $59.93M derived: sum of 2 quarters · filed 2026-03-03 | $111.52M derived: sum of 3 quarters · filed 2026-03-03 | $117.23M 10-K · filed 2026-03-03 | $189.77M 10-K · filed 2025-03-13 | |||
| 2024-09-30 | $28.55M 10-Q · filed 2025-11-10 | $55.04M 10-Q · filed 2024-11-12 | $80.14M derived: sum of 2 quarters · filed 2025-11-10 | $85.85M 10-Q · filed 2025-11-10 | $148.01M 10-Q · filed 2024-11-12 | $159.99M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $51.59M 10-Q · filed 2025-08-05 | $92.97M 10-Q · filed 2025-08-05 | $131.43M derived: sum of 3 quarters · filed 2025-08-05 | $187.30M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $41.38M 10-Q · filed 2025-05-12 | $79.84M derived: sum of 2 quarters · filed 2025-05-12 | $135.71M derived: sum of 3 quarters · filed 2025-05-12 | $186.33M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $38.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $94.33M derived: sum of 2 quarters · filed 2025-03-13 | $144.95M derived: sum of 3 quarters · filed 2025-03-13 | $183.06M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $55.86M 10-Q · filed 2024-11-12 | $106.48M derived: sum of 2 quarters · filed 2024-11-12 | $144.59M 10-Q · filed 2024-11-12 | $177.75M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $50.62M 10-Q · filed 2024-08-08 | $88.73M 10-Q · filed 2024-08-08 | $121.89M derived: sum of 3 quarters · filed 2024-08-08 | $158.34M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $38.11M 10-Q · filed 2024-05-07 | $71.27M derived: sum of 2 quarters · filed 2024-05-07 | $107.72M derived: sum of 3 quarters · filed 2024-05-07 | $138.25M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $33.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $69.62M derived: sum of 2 quarters · filed 2024-03-12 | $100.14M derived: sum of 3 quarters · filed 2024-03-12 | $123.84M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $36.46M 10-Q · filed 2023-11-08 | $66.98M derived: sum of 2 quarters · filed 2023-11-08 | $90.69M 10-Q · filed 2023-11-08 | $111.36M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $30.52M 10-Q · filed 2023-08-09 | $54.23M 10-Q · filed 2023-08-09 | $74.91M derived: sum of 3 quarters · filed 2023-08-09 | $90.76M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $23.71M 10-Q · filed 2023-05-11 | $44.38M derived: sum of 2 quarters · filed 2023-05-11 | $60.24M derived: sum of 3 quarters · filed 2023-05-11 | $70.22M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $20.68M 10-K · filed 2023-03-16 | $20.64M 10-QT · filed 2022-02-10 | $36.53M derived: sum of 2 quarters · filed 2023-03-16 | $46.51M derived: sum of 3 quarters · filed 2023-03-16 | $54.30M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-09-30 | $15.86M 10-Q · filed 2022-11-10 | $25.83M derived: sum of 2 quarters · filed 2022-11-10 | $33.63M 10-Q · filed 2022-11-10 | $40.01M 10-K · filed 2023-03-16 | $39.72M 10-K · filed 2021-12-20 | |||
| 2021-06-30 | $9.98M 10-Q · filed 2022-08-09 | $17.77M 10-Q · filed 2022-08-09 | $24.14M derived: sum of 3 quarters · filed 2023-01-10 | |||||
| 2021-03-31 | $7.80M 10-Q · filed 2022-05-10 | $14.16M derived: sum of 2 quarters · filed 2023-01-10 | ||||||
| 2020-12-31 | $6.37M 8-K · filed 2023-01-10 | |||||||
| 2020-09-30 | $21.11M 10-K · filed 2021-12-20 | |||||||
| 2019-09-30 | $26.50M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |